Psychological support in one of the world's best-organised Huntington's disease systems is delivered in a sequence tied to disease stage, according to a qualitative study of Dutch practice published in Psychology and Psychotherapy: Theory, Research and Practice (2026;99:443-462, first published online 23 December 2025). Kasper F. Van der Zwaan and colleagues at Leiden University Medical Centre interviewed 13 experienced psychologists working in Dutch HD care facilities, in semi-structured interviews held between 23 May and 11 December 2023 totalling 14 hours and 5 minutes, and analysed them thematically. Their account: at the at-risk, premanifest and early manifest stages, work centres on genetic counselling and trauma therapy, including eye movement desensitisation and reprocessing (EMDR); as symptoms and functional decline advance, acceptance and commitment therapy (ACT) and cognitive behavioural therapy (CBT) become more prominent; in late-stage disease, support shifts to mediated approaches delivered through family members and care teams. Psychoeducation and structured supportive conversation techniques run across the whole trajectory.
The study is a description of clinical practice, not a test of it. It reports what these psychologists say they do and why, and it names the points at which the work stops. The barriers the authors identify include cognitive impairment, anosognosia and avoidant coping, in which, as the paper puts it, patients may resist interventions or dismiss the severity of their symptoms. Four of the 13 said that referrals of HD patients to other, non-HD mental health providers are sometimes unavoidable, for trauma processing or other comorbid conditions, but that those providers may be unfamiliar with HD and may misattribute unrelated symptoms to the disease. The suggested fix in the paper is not a new therapy but a role: HD psychologists acting as consultants to colleagues outside HD services. Facilitators reported were multidisciplinary collaboration, preventive work started early, and flexible use of parts of standard protocols rather than whole ones.
The detail matters for families because it shows how much of the support is aimed at people who have no diagnosis. Psychological need in HD begins with being at risk, with predictive testing decisions and family planning, long before any motor onset, and the Dutch inventory reflects that. It also shows that in late disease the psychologist's client is often, in practice, the household and the care team rather than the person with HD alone. On EMDR, the psychologists were not unanimous: the paper records national discussion about whether trauma treatment in HD really differs from standard practice, and reports that of three who raised so-called flashforward techniques for anticipatory fears about the disease, only one had used the approach, without a noticeable positive effect.
The Dutch picture should be read as a ceiling rather than a norm. In Italy, a separate qualitative study of 14 people (7 patients with early-manifest HD and 7 partners acting as carers), published in NeuroSci on 28 March 2024 by Nicolo Zarotti and colleagues, found that participants perceived public psychological support for HD as unavailable or inadequate and private therapy as often unaffordable. Neither study measures whether any of these interventions improves symptoms or quality of life; both describe access and practice, in small samples, in single countries.